Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.

Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.

Item
http://www.wikidata.org/entity/Q43895100
Comparison of Two Commercial Automated Nucleic Acid Extraction and Integrated Quantitation Real-Time PCR Platforms for the Detection of Cytomegalovirus in PlasmaCommutability of Cytomegalovirus WHO International Standard in Different Matrices.Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?Quantification of cytomegalovirus viral load.Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients.Lack of evidence for a reciprocal interaction between bacterial and cytomegalovirus infection in the allogeneic stem cell transplantation setting.When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood.Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients.Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients.The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.Active cytomegalovirus infection is not a risk factor for Epstein-Barr virus DNAemia in the allogeneic stem cell transplantation setting.
P2860

Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.

Item
http://www.wikidata.org/entity/Q43895100
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Comparison of the new Abbott R ...... lasma cytomegalovirus DNAemia.
@en
Comparison of the new Abbott R ...... lasma cytomegalovirus DNAemia.
@nl
type
label
Comparison of the new Abbott R ...... lasma cytomegalovirus DNAemia.
@en
Comparison of the new Abbott R ...... lasma cytomegalovirus DNAemia.
@nl
prefLabel
Comparison of the new Abbott R ...... lasma cytomegalovirus DNAemia.
@en
Comparison of the new Abbott R ...... lasma cytomegalovirus DNAemia.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Comparison of the new Abbott R ...... lasma cytomegalovirus DNAemia.
@en
P2093
P304
P31
P356
10.1016/J.DIAGMICROBIO.2012.10.010
P433
P478
P577
P5875
P698